Vital Signs with Jacob Effron and Nikhil Krishnan cover image

Ep 52: knownwell CMO Dr. Angela Fitch on The Future of GLP-1s and New Approaches to Obesity Medicine

Vital Signs with Jacob Effron and Nikhil Krishnan

00:00

Exploring the Broad Benefits of GLP-1 Medications

This chapter explores the evolving applications of GLP-1 medications, highlighting their potential in treating not just obesity but also conditions like Alzheimer's and cardiovascular issues. The discussion examines the possibility of these drugs playing a significant role in long-term disease modification and their broader implications for patient care.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app